Recent studies suggest that the hydroxyl radical (-OH) plays a pathogenetic role in postischemic ventricular dysfunction (myocardial "stunning"). This concept, however, is predicated exclusively on results obtained in anesthetized open-chest preparations, which are subject to the confounding influence of many unphysiological conditions and in which both myocardial stunning and free radical generation are greatly exaggerated. The lack of supporting evidence in more physiological animal models represents a major limitation of the -OH hypothesis of stunning. Furthermore, concern has been raised that myocardial stunning may be a period of "rest" necessary for full recovery, so that attenuation of the early phase of stunning by antioxidant therapy may have subsequent detrimental effects on the resting function and/or on the return of myocardial contractile reserve. To address these issues, in phase 1 of this study conscious unsedated dogs undergoing a 15-minute coronary artery occlusion received an intravenous infusion of normal saline (n=22), of the -OH scavenger N-2-mercaptopropionyl glycine (MPG, n=17), or of the iron chelator desferrioxamine (DF, n= 14). Compared with control dogs, the dogs treated with MPG or DF exhibited significantly greater postischemic wall thickening throughout the first 6 hours of reperfusion; the total deficit of wall thickening during this time interval was reduced 509% by MPG and 59%1 by DF. The magnitude of this beneficial effect was a function of the severity of ischemia, so that the dogs with the lowest collateral flows had the greatest improvement of wall thickening. The accelerated recovery produced by MPG and DF in the first 6 hours was not followed by any deterioration of resting wall thickening at 24 or 48 hours. Furthermore, in dogs treated with MPG or DF, the increase in wall thickening elicited by maximal inotropic stimulation (isoproterenol or dopamine) was similar before stunning and shortly after resting wall thickening had normalized (24 or 48 hours after reflow); thus, despite the fact that most of the early postischemic dysfunction had been eliminated by antioxidant therapy, there was no subsequent impairment of either resting function or contractile reserve. In phase 2, production of free radicals (measured with the spin trap a-phenyl N-tert-butyl nitrone) was markedly (>809%) inhibited by the same doses of MPG and DF that attenuated stunning in phase 1. This study demonstrates that in the conscious dog both the severity of postischemic dysfunction and the concomitant production of free radicals are attenuated markedly, and to a similar degree, by antioxidants that scavenge -OH (MPG) or prevent its generation (DF). These results indicate that the beneficial effects of "anti-'OH" therapy are independent of the exaggerated free radical production caused by open-chest preparations and provide direct evidence that *OH plays an important role in the pathogenesis of myocardial stunning under physiological conditions. Furthermore, our results indicate that myocardial stunning is not a teleologically useful phenomenon and that it can be safely prevented without fear of detrimental effects. (Circ Res. 1993;73:705-723.) KEY
thereby prevent iron-catalyzed generation of *OH, such as desferrioxamine (DF)5-8 and conjugated DF.910 MPG and DF have also been shown to attenuate the production of free radicals in the stunned myocardiuM. 37 A major limitation of all of these previous investigations,1-10 however, is that they were conducted in anesthetized open-chest preparations. To our knowledge, no information is available regarding the role of -OH in myocardial stunning in the conscious animal. Observations obtained in anesthetized open-chest models are beset by multiple confounding factors, including anesthesia, mechanical ventilation, surgical trauma, lack of integrity of the chest wall, fluctuations in temperature, unphysiological hemodynamic conditions, excessive levels of circulating catecholamines, and other abnormalities. Indeed, we have recently found that the severity of myocardial stunning is greatly exaggerated in open-chest as compared with conscious dogs; i.e., the postischemic depression of contractility observed in the anesthetized preparation is approximately double that in the awake dog.12 There is also a clear difference in the time course of recovery of myocardial function between these two models. In open-chest normothermic dogs, the recovery of function stops at 1 hour after reperfusion with no further improvement between 1 and 4 hours of reflow35-7,9,10.12-15; in contrast, in the conscious dog, the recovery continues throughout the first 6 hours of reperfusion and beyond until complete normalization is achieved.12416 '7 More recently, we have observed that the production of free radicals in the stunned myocardium is also greatly exaggerated in anesthetized as compared with awake dogs, being three to five times greater in the former. 18 Since both the phenomenon of stunning and the intensity of the attending radical reactions are markedly distorted in the open-chest preparation, results obtained in this preparation may not be applicable to the conscious animal. There are numerous examples of conclusions derived from open-chest models that could not be substantiated in more physiological conscious models. [19] [20] [21] [22] [23] [24] If current concepts regarding the pathogenetic role of oxyradicals are to be extrapolated to humans and used as a basis for developing clinical therapies, evidence must be provided that such concepts are valid in the absence of the abnormal conditions associated with open-chest preparations.
There are additional reasons for testing the role of -OH in awake animals. Although many studies'-10 have shown that "anti--OH" therapy enhances the early recovery of the stunned myocardium, the effects of such therapy after the first 4 hours of reperfusion are unknown. Stunning extends beyond the time window (4 hours) examined in these studies' 10; for example, in conscious dogs subjected to a 15-minute occlusion, 24 hours is required for left ventricular (LV) wall thickening to normalize.16 By accelerating the return of function in the stunned myocardium, anti--OH therapy causes systolic work to increase considerably in the early phase after reperfusion. What are the effects of this manipulation on the later phase of recovery and on the ability of the myocardium to respond to stress? Is the improvement in contractile function sustained over 24 to 48 hours after reperfusion, and if so, does myocardial contractile reserve normalize in parallel with resting function, or does it lag behind? Alleviating myocardial dysmay not be a sufficient therapeutic achievement because this is only a small fraction of the entire phenomenon of stunning. To be physiologically and clinically meaningful, the improved recovery must be shown to continue beyond 4 hours. Moreover, it is not clear that attenuating the early phase of stunning is necessarily beneficial. Concern has been raised that stunning may be a useful sequela of ischemia/reperfusion, indeed, that it may be necessary to allow full recovery, so that attempts to eliminate stunning may actually be detrimental. There is no information on what effect the attenuation of the early phase of stunning will have on the subsequent time course of resting function and on the return of myocardial contractile reserve.
In summary, two important (and related) questions need to be addressed: (1) Does -OH play a major pathogenetic role in myocardial stunning in the conscious animal? (2) If so, does the acceleration of the early functional recovery by anti-OH therapy result in subsequent deterioration of resting function and/or in delayed return of myocardial contractile reserve?
The present study was conducted to address these issues. The -OH hypothesis was tested by examining the effects of MPG and DF on the recovery of contractile function and on the production of free radicals in conscious dogs undergoing a 15-minute coronary occlusion followed by reperfusion. MPG is a powerful scavenger of -OH with no effect on superoxide anion (-02 ) or hydrogen peroxide (H202).3 DF chelates iron and therefore prevents formation of -OH through the Haber-Weiss reaction. 25 Since MPG and DF inhibit -OH-initiated reactions by two completely different mechanisms, we reasoned that simultaneous evaluation of these two agents could provide strong support for a pathogenetic role of -OH and could also give information regarding the relative efficacy of scavenging -OH versus preventing -OH formation. To obtain direct evidence for the oxyradical hypothesis, the effects of MPG and DF on free radical production were assessed with the use of the spin trap a-phenyl N-tert-butyl nitrone (PBN) and electron paramagnetic resonance (EPR) spectroscopy. The effect of anti--OH therapy on contractile reserve was evaluated by infusing maximally stimulating doses of isoproterenol or dopamine before and shortly after stunning in dogs treated with MPG or DF. By comparing the inotropic response at these two time points, we sought to determine whether the accelerated early recovery induced by antioxidant therapy was achieved at the expense of a subsequent persistent deficit of contractile reserve.
Materials and Methods
A total of 120 dogs were used (116 for phases 1 and 2 and four for the pharmacokinetics of MPG). The experimental preparation and techniques have been previously described in detail.371214-17. 26 The present study was performed in accordance with the guidelines of the Committee on Animals of Baylor College of Medicine and with the "Guide for the Care and Use of Laboratory Animals" (Department of Health and Human Services, publication No. [NIH] 86-23).
Phase 1: Studies of the Effect of MPG and DF on Recovery of Contractile Function
Experimental preparation. Eighty-six healthy mongrel function in the first 4 hours of reperfusion, in and of itself, dogs of either sex (14 to 31 kg) were instrumented using sterile techniques as previously described.12,16417,26 Briefly, a high-fidelity micromanometer (model P7, Konigsberg Instruments, Inc, Pasadena, Calif) was introduced into the LV cavity via an apical stab wound; a hydraulic balloon occluder was implanted around the mid left anterior descending coronary artery (LAD); a Doppler flow probe was inserted around the LAD distal to the occluder; and Tygon catheters were placed in the aorta, left atrium, and jugular vein. To measure wall thickening, 10-MHz pulsed Doppler ultrasonic probes16 were placed in the center of the region to be rendered ischemic and on the posterior (control) LV wall. The chest was closed in layers, and a small tube was left in the thorax to evacuate air and fluid after surgery. Antibiotics were administered during the perioperative period. Dogs were allowed to recover for a minimum of 7 days after surgery and were trained for 2 to 3 days so that they became acclimatized to the laboratory environment.
Experimentalprotocol. kg`* h-1). To achieve the desired dose, 500 mg DF was dissolved in 100 mL normal saline, and this solution was infused at a rate of 0.0445 mL-kg-1 * min-l.
Measurement of MPG plasma concentration. In dogs treated with MPG, venous blood samples (5 mL) were obtained at baseline and at 1, 30, 40, 50 , and 60 minutes after reperfusion. The specimens were immediately centrifuged, and the plasma was frozen at -70C for subsequent analysis. The total concentration of reduced sured by a spectrophotometric method.27 Since the concentration of nonprotein sulfhydryl groups in the plasma is normally low and since MPG contains a reduced sulfhydryl moiety, most of the nonprotein thiol groups measured after administration of MPG were accounted for by this substance. Indeed, the non-MPG nonprotein sulfhydryl groups were measured before starting the infusion of MPG and were found to be quite low (<20 ,umol/L); in each dog, these "background" values were subtracted from all subsequent measurements during and after MPG infusion to give the concentration of MPG-related thiol groups.
Pharmacokinetics ofMPG. To determine the pharmacokinetics of MPG, a separate group of four conscious dogs was given an intravenous infusion of MPG at a rate of 100 mg kg'. h`1 for 2.5 hours (total dose, 250 mg/kg). The concentration of MPG in the arterial plasma was measured at 0.5, 1, 1.5, and 2 hours into the infusion of MPG, at the end of the infusion, and at 2, 5, 10, 15, 20, 30, 40, 50 , and 60 minutes and 1.5, 2, 2.5, 3, 3.5, and 4 hours after the end of the infusion. The area under the curve was calculated by the trapezoidal rule and extrapolated to infinity. The pharmacokinetic parameters were calculated according to standard equations. The terminal elimination half-life was determined by linear regression using at least three concentrations.
Effect of antioxidant therapy on contractile reserve. To determine whether the accelerated recovery effected by antioxidant therapy results in any impairment of myocardial contractile reserve, dogs treated with MPG or DF received intravenous infusions of incremental doses of inotropic agents before stunning (on the day prior to coronary occlusion) and soon after recovery from stunning (24 or 48 hours after reperfusion). In one group of dogs, dopamine was infused on the day before coronary occlusion at rates of 10, 20, and 30 g . kg-1 . min`(5 minutes for each rate), followed by a 1-hour infusion of 20 ,gg kg`. min-m. This same protocol was repeated 48 hours after reperfusion. Another group of dogs received isoproterenol on the day before coronary occlusion at rates of 0.04,0.08, and 0.12 ,ug * kg`. min-m (5 minutes for each rate), followed by a 1-hour infusion of 0.08 ugg kg`. min`l. This same protocol was repeated 24 hours after reperfusion. The inotropic response measured after reperfusion was compared with the response observed under control conditions (before occlusion), so that each dog served as its own control. The infusion rates were selected on the basis of pilot studies, which showed that doses of isoproterenol >0.12 ,ug . kg-1 minm or doses of dopamine >30 gg . kg-*. min-m did not produce additional effects on wall thickening in normal myocardium.
Postmortem tissue analysis. At the end of the study, the animals were anesthetized with pentobarbital sodium and killed with a bolus of KCl. The size of the occluded coronary vascular bed was determined by a previously described postmortem dual-perfusion technique. 16 The heart was then cut into 1.0-cm-thick transverse slices, which were incubated for 20 minutes at 38°C in a 1% solution of triphenyltetrazolium chloride (TTC) to verify the absence of infarction. After TTC staining, four transmural specimens (1 to 2 g) were obtained from both the ischemic/reperfused and nonischemic regions. To avoid admixture of ischemic and nonischemic tissue, ischemic specimens were obtained at least 1 cm inside the boundaries of the occluded bed. Each nonprotein sulf hydryl groups in the plasma was mea-specimen was divided into endocardial and epicardial halves, weighed, and placed in scintillation vials containing 10% neutral buffered formalin. Regional myocardial blood flow was calculated by standard methods. 16 Measurement ofregional myocardialfunction. Regional myocardial function was assessed as systolic wall thickening using a pulsed Doppler probe, as previously described.1-3,5 7, [12] [13] [14] [15] [16] [17] 26, 28, 29 The beginning and end of systole were determined from the onset of the rapid upstroke of the LV pressure tracing and the peak negative LV dP/dt, respectively.16 Percent systolic thickening fraction was calculated as the ratio of net systolic thickening to end-diastolic wall thickness, multiplied by 100. 16 The total deficit of wall thickening in the first 6 or 24 hours after reperfusion (an integrative assessment of the severity of postischemic dysfunction) was calculated by measuring the area between the wall thickeningversus-time line and the baseline (100% line) during the first 6 or 24 hours of reflow. '2 In the conscious dog, the presence of sinus arrhythmia causes beat-to-beat changes in the duration of diastole, which are associated with significant beat-tobeat variations in wall thickening, presumably due to the concomitant changes in LV end-diastolic volume. To minimize the impact of this variability as a confounding factor, in each dog a narrow range of cardiac cycle durations (RR intervals) was selected and precisely defined before measurements. Throughout the protocol, only beats that followed RR intervals within the predetermined range were analyzed.'6 The criteria used in selecting the range were as follows: (1) Dogs included in study, n 22 (63%)t 17 (55%)t 14 (70%)t 6 (32%)t 6 (55%)t 65 (56%)t MPG indicates N-2-mercaptopropionyl glycine; DF, desferrioxamine; and LAD, left anterior descending coronary artery.
*Most of these deaths were attributed to hemothorax secondary to continuous heparin infusion.
tPercentage of dogs instrumented.
Because postischemic recovery of function is determined primarily by collateral flow,12"16 the relation between these two variables was analyzed using an exponential regression equation: Y=100+Pl(e-P2X-e P2100), as detailed previously.12"6 The exponential regression lines generated by these regression equations were then compared. Briefly, for every 5% increment in X (collateral blood flow) from 0% to 100%, the Regional myocardial blood flow. Baseline myocardial blood flow did not differ among control, MPG-treated, and DF-treated dogs (Table 3) . During coronary occlusion, the average blood flow to the ischemic region was similar in control and treated groups (Table 3) , but there was considerable individual variability (Fig 2) . It has been previously demonstrated '2,16 that in the conscious dog the rate of contractile recovery after a 15-minute coronary occlusion is highly variable and that this variability is determined primarily by the severity of blood flow reduction during the antecedent ischemia. Accordingly, in an effort to analyze recovery of function in relatively homogeneous subgroups of animals, we partitioned dogs (as we have done previously12) into subset 1 (collateral flow, <10% of simultaneous nonischemic zone flow [NZF]), subset 2 (collateral flow, between 10% and 30% of NZF), and subset 3 (collateral flow, >30% of NZF) (Fig 3) . (The average flows and sample sizes for each subset are specified in the legend to Fig 3. ) It is recognized that any subdivision of animals on the basis of collateral flow is arbitrary. However, we also partitioned the dogs using other cutoff points (such as 15% of NZF) and found the results to be similar to those obtained by using 10% and 30% of NZF. Thus, the conclusions derived from the subset analysis are not dependent on the specific values of flow selected as cutoff points.
At 1 hour of reperfusion, there was no significant difference between control and treated groups with respect to regional myocardial blood flow in the ischemic or nonischemic zones (Table 3) . Similarly, Doppler measurements of LAD blood flow failed to reveal any difference between control and treated groups at any time point after reperfusion (Table 2 ). These results indicate that the faster recovery of function observed in MPG-and DF-treated dogs compared with control dogs cannot be attributed to increased blood flow to the postischemic myocardium.
Regional myocardialfunction. Systolic thickening fraction in the nonischemic (control) region did not differ significantly between control and treated dogs at any time point during the protocol (Table 2 ). In the ischemic region, the extent of paradoxical systolic thinning during coronary occlusion was similar in all three groups (Fig 4) . After reperfusion, control dogs exhibited delayed recovery of contractile function, indicating myocardial stunning. In dogs treated with MPG or DF, however, the recovery of contractile function was considerably faster (Fig 4) . Thickening fraction was significantly greater than in control dogs at 2, 3, 4, 5, and 6 hours of reperfusion in the MPG-treated group and at all time points from 1 to 6 hours of reperfusion in the DF-treated group. Interestingly, the magnitude of protection afforded by MPG and DF was similar (Fig 4) . In comparison with the control group, the total deficit of wall thickening during the initial 6 hours of reperfusion (an integrative assessment of postischemic dysfunction in the phase when it was most severe) was reduced by 50% in the MPG-treated group and by 50% in the DF-treated group; the total deficit of wall thickening during the first 24 hours of reperfusion (an integrative assessment of total postischemic dysfunction) was Relation between recovery of function and collateral flow. When recovery of function is examined in different categories of collateral flow (subsets 1, 2, and 3), it becomes apparent that the effects of antioxidant therapy were not uniform in the various ranges of ischemic zone perfusion (Fig 3) . In subset 1 (collateral flow, < 10% of NZF), the severity of myocardial stunning in control animals was greater than that observed in the entire group of dogs (Fig 3, top) . The enhancement of contractile recovery by antioxidants was also greater than that observed in the entire group of animals, with statistical significance achieved as early as 30 minutes after reperfusion and sustained throughout 6 hours (Fig  3, top) . In subset 2 (collateral flow, 11% to 30% of NZF), the severity of myocardial stunning in the control group was less than that in subset 1 (Fig 3, middle) . Although thickening fraction after reperfusion was greater in treated compared with control dogs, the differences were smaller than in subset 1 and achieved statistical significance only at 4, 5, and 6 hours of reflow.
In subset 3 (collateral flow, >30% of NZF), very little myocardial stunning was observed in control animals, and no significant improvement was noted with either MPG or DF (Fig 3, bottom) . Thus, the beneficial effects of both MPG and DF were directly related to the severity of myocardial ischemia.
This concept can be further appreciated when one examines the relation between wall thickening after values. Note that in the lower collateral flow range both of the treated groups exhibit greater wall thickening than the control group, particularly at the earlier time points, while in the higherflow range there is considerable overlap between all three groups. Note also that the relation between collateral flow and wall thickening is nonlinear.
reperfusion and collateral flow during occlusion. Fig 2 illustrates the data for individual dogs. It is apparent that, in control animals, the relation between thickening fraction and collateral flow is nonlinear, and we have previously demonstrated that such a relation is best described by an exponential regression equation.1216 The regression lines of the exponential equations relating thickening fraction at 1, 2, 4, and 6 hours of reperfusion to collateral flow during occlusion are depicted in Fig 5; the corresponding equations are specified in the legend to this figure. In the low range of collateral flows, the regression lines for the MPG-and DF-treated groups are shifted upward and to the left with respect to the control group; ie, for any given level of collateral flow in this range, wall thickening after reperfusion was greater in treated than in control dogs. Statistical analysis (approximate normal test) confirmed that the exponential regression lines in the two treated groups were significantly different from the control line in the range of collateral flows of 0% to 25% of NZF but not at flows of >25% of NZF. Furthermore, the distance between the regression lines increases as collateral flow decreases, indicating that the beneficial effects of MPG and DF were proportionately greater in animals with lower levels of collateral perfusion. Finally, Fig 5 demonstrates that the beneficial effects of MPG were equivalent to those of DF in all ranges of collateral flow, again reinforcing the notion that these two antioxidants afford similar protection against stunning.
Effect ofantioxidant therapy on contractile reserve. In a subset of 16 treated dogs, an inotropic agent (isoproterenol or dopamine) was infused on the day before occlusion and again 24 hours (isoproterenol) or 48 hours (dopamine) after reperfusion. Both the isoproterenol group and the dopamine group included 8 animals (all treated with DF in the isoproterenol group; 4 treated with MPG and 4 treated with DF in the dopamine group). As shown in Table 4 , heart rate, systolic arterial pressure, rate-pressure product, and peak positive LV dP/dt were similar on the day before occlusion and after reperfusion, both at baseline and during inotropic stimulation, with few exceptions. In the isoproterenol group, baseline systolic arterial pressure 24 hours after reperfusion was slightly higher than the corresponding preocclusion value. However, because of a slightly faster preocclusion baseline heart rate (not significant), the baseline rate-pressure products did not differ significantly on the day before occlusion and 24 hours after reperfusion. At baseline as well as during isoproterenol, these dogs also had higher values of peak positive LV dP/dt at 24 hours of reperfusion compared with preocclusion. The reasons for these hemodynamic differences are unknown, but it is important to point out that the percent increases in LV dP/dt elicited by isoproterenol after reperfusion were similar to those elicited before occlusion. In the dopamine group, there were no significant hemodynamic differences between the day before occlusion and 48 hours after reperfusion.
In the isoproterenol group, the baseline systolic thickening fraction in the LAD-dependent region was similar on the day before occlusion and 24 hours after reperfusion (25.9±+ 2.3% and 26.3±+-2.7%, respectively).
Thickening fraction increased with increasing doses of isoproterenol (Fig 6, left) , so that, at the highest dose (0.12 ,g g kg -min-1), the values achieved were 26 .1+4.8% greater than baseline on the day before occlusion and 29.0+6.6% greater than baseline 24 hours after reperfusion. The increases in thickening fraction elicited by all three doses of isoproterenol (0.04, 0.08, and 0.12 gg -kg-1' min-1) on the day before occlusion and 24 hours after reperfusion were similar (Fig 6, left) . Likewise In the circumflex-dependent (control) region, wall thickening during isoproterenol was similar before occlusion and 24 hours after reperfusion at most time points (Fig 6, right) ; however, at the highest dose (0.12 gg * kg-min-1) and at 30 minutes into the 1-hour infusion of 0.08 ,gg kg1 min-1, wall thickening was significantly greater after reperfusion than before occlusion (Fig 6, right) . The reason for these sporadic differences is unknown; it may reflect the fact that, at both time points, the preocclusion response was unexpectedly small relative to the preocclusion response noted in the LAD-dependent region (Fig 6) .
In the dopamine group, the baseline thickening fraction in the LAD-dependent region averaged 27.4±2.5% on the day before occlusion and 27.1±7.2% 48 hours after reperfusion. Thickening fraction increased with increasing doses of dopamine (Fig 7, left) , and at the highest dose (30 .gg* kg`* min-'), it exceeded baseline (Fig 7, left) . In the control region, the response to dopamine was similar on the day before occlusion and 48 hours after reperfusion (Fig 7, right) , again indicating that the changes induced by inotropic stimulation were reproducible over time. In summary, shortly after recovery from stunning (24 or 48 hours after reperfusion), the contractile reserve of the previously ischemic myocardium was similar to the reserve measured in the same myocardium before ischemia, despite the fact that the recovery from stunning had been accelerated by antioxidant therapy. Hemodynamic variables, occluded bed size, and myocardial blood flow. In general, all hemodynamic variables (heart rate, systolic arterial pressure, rate-pressure product, LAD blood flow, and peak positive and negative LV dP/dt) were similar in the control group and in the two (Table  5 ). Control and treated groups were comparable with respect to the size of the occluded bed, which averaged 24.2±1.9 g (28.5±2.1% of LV weight) and 26.9±2.9 g (22.6±2.4%), respectively. There were no significant differences among the three groups with respect to regional myocardial blood flow at baseline or during coronary occlusion (Table 3) . Myocardial production of PBN adducts. Fig 8 summa rizes the time course of release of PBN adducts from the ischemic/reperfused region in control, MPG-treated, and DF-treated dogs. In control dogs, EPR signals characteristic of radical adducts of PBN appeared in the coronary venous effluent immediately after reperfusion. The release of PBN adducts exhibited an initial burst peaking 3 minutes after reperfusion and then declined markedly. After the first hour of reperfusion, spin adduct release was barely detectable (Fig 8) . In the dogs that received MPG and DF, PBN adduct production was markedly reduced compared with control dogs (Fig  8) . As was the case for the attenuation of stunning in phase 1, the magnitude of the attenuation of free radical production by MPG and DF in phase 2 was similar. In the first 5 minutes of reperfusion, the total cumulative release of PBN adducts was decreased by 87% in MPG-treated dogs and 92% in DF-treated dogs (Fig 9) ; in the first 10 minutes of reperfusion (interval encompassing the entire burst of spin adduct production), the total cumulative release of PBN adducts was reduced by 87% and 89%, respectively (Fig 9) . In contrast to control dogs, in which production of spin-trapped radicals continued for up to 5 hours, adduct production ceased completely by 1 hour in MPG-treated dogs and by 2 hours in DF-treated dogs (Fig 8) . The total cumulative adduct release during the 6 hours of reperfusion was decreased by 91% in MPG-treated animals and 79% in DF-treated animals (Fig 9) .
PBNplasma concentration. The concentration of PBN in the arterial plasma was similar in the three groups. The following measurements were obtained in control, MPG-treated, and DF-treated dogs, respectively: 2 minutes after reperfusion, 292+22, 258±22, and 334±75 (DF) , that such attenuation is sustained for at least 6 hours after reflow, and that it is associated with marked suppression of free radical production in the reperfused myocardium. The degree of protection afforded by MPG and DF was similar, suggesting a common mechanism of action. The present results further indicate that the magnitude of the beneficial effects of MPG and DF on stunning is a function of the severity of ischemia: the lower the collateral perfusion, and thus the more severe the ischemia, the greater the improvement of function effected by the antioxidants.
:hemlc Zone Because of these striking model-dependent disparities, it is unknown whether the -OH hypothesis, which is predicated exclusively on studies in open-chest animals, is applicable to conscious animals. In view of the large differences in both postischemic dysfunction and free radical production between the two models, conclusions derived from anesthetized animals cannot be extrapolated to awake animals. In particular, it is unclear (1) Furthermore, it appears that Vogelaers et a138 studied a group of dogs with moderate-to-mild ischemia, in which a protective therapeutic effect is difficult to demonstrate unless large sample sizes are used. Although collateral flow was not specified, the fact that active systolic wall thickening was observed during occlusion38 indicates the lack of severe ischemia. In our experience in conscious dogs,12"16 the presence of residual wall thickening during occlusion is invariably associated with collateral flows of >20% of NZF. These considerations suggest that the animals studied by Vogelaers et al were similar to our combined subsets 2 and 3, in which stunning was mild and statistically significant differences between control and treated dogs were mostly absent. Finally, the dose of DF used by Vogelaers et al was much higher than ours (550 mg' In the present study, we found that the increased wall thickening produced by antioxidants early after reperfusion was not followed by any deterioration at 24 or 48 hours, indicating that mitigation of stunning does not adversely affect resting LV function. Nevertheless, it is possible that attenuation of stunning may have more subtle detrimental effects, which are reflected in a loss of inotropic reserve rather than in a decrease of resting function. To address this possibility, we evaluated inotropic reserve with dopamine or isoproterenol at baseline (before stunning) and then again 24 and 48 hours after reperfusion (shortly after resting function had normalized). We reasoned that, if the increased wall thickening caused by MPG or DF had "deprived" the heart of a necessary "rest period" and thereby prevented complete recovery, the response to inotropic stimulation should be impaired. However, we found no evidence to support this idea. The response to all doses of inotropic agents was similar before and after stunning, even at maximally stimulating infusion rates of dopamine (30 gg . kg-1 . min-1) and isoproterenol (0.12 jig. kg-1 . min-1). Furthermore, this normal inotropic response was sustained over time, as demonstrated by the fact that the effects of a prolonged (1-hour) infusion of dopamine or isoproterenol were also similar before and after stunning. Thus, the recovery of contractile reserve did not lag behind the recovery of resting function.
In conclusion, despite the fact that most of the early postischemic dysfunction had been eliminated by antioxidant therapy, there was no subsequent impairment of either resting function or inotropic reserve at 24 or 48 hours, indicating that by this time the contractile recovery was indeed complete. There results strongly argue against the notion that stunning is a useful phenomenon. Furthermore, they have therapeutic implications because they suggest that stunning can be safely prevented without fear of producing detrimental effects.
Clinical Implications
The concept that *OH is a major culprit in postischemic dysfunction under physiological conditions could have significant implications. There are numerous clinical settings in which the myocardium is exposed to transient ischemia followed by reperfusion.49,50 Mounting evidence suggests that these situations are associated with variable degrees of myocardial stunning, which may be an important factor precipitating LV failure with its attendant morbidity. 49, 50 The results of the present study suggest that effective reduction of postischemic myocardial dysfunction can be obtained with pharmacologic manipulations that either scavenge -OH or prevent its generation. DF is already used clinically for other reasons. MPG has been found to be beneficial in the treatment of patients affected by various disorders linked to abnormal free radical production51-53; this drug has been used clinically in Europe and Japan for nearly two decades and is generally reported to be well tolerated.51'53 Therefore, further investigation of DF and MPG as possible prophylactic treatments against myocardial stunning appears warranted.
